December 25, 2024 07:37 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Azerbaijan Airlines passenger plane enroute to Russia with over 70 people onboard crashes in Kazakhstan | Atishi will be arrested in fake case, claims Arvind Kejriwal after Delhi govt disowns health and women's schemes | Delhi govt departments disown Arvind Kejriwal's major poll promises, AAP chief reacts | 'Our nation will always be grateful to him': PM Modi writes article in tribute to Atal Bihari Vajpayee on his birth centenary | Syria: Christmas tree set on fire by suspected 'Islamists', Christians protest | Pakistan strikes TTP camps in Afghanistan, Taliban government claims civilians killed | Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US
Sanofi, Regeneron announce positive Dupilumab Topline results from two phase 3 trials

Sanofi, Regeneron announce positive Dupilumab Topline results from two phase 3 trials

Apr 02, 2016, at 04:39 am

Kolkata/Paris, Apr 1 (IBNS) Sanofi and Regeneron Pharmaceuticals, Inc. announced that two placebo-controlled Phase 3 studies evaluating investigation dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD) met their primary endpoints.